Each year, we invest a large part of the money we raise in research which aims to stop people dying from blood cancer, make their lives better, and stop people getting blood cancer in the first place.
For Hodgkin lymphoma, we’re looking for new drugs to treat people who don’t respond well to standard treatments, or who are not fit enough to have them. We’re also interested in reducing the side effects of treatment as much as possible.
Find out more about Bloodwise’s Hodgkin lymphoma research and clinical trials.
You can also search for details of national clinical trials by disease name and location at the UK Clinical Trials Gateway.